Skip to contents

Interventions contains the historical intervention information for a site. It is also the section of the site file that you would modify with intervention information for future scenarios. Details, references and methods for individual interventions are shown below:

Note on time: The model assumes all years have 365 days (no leap years). Intervention time points are therefore specified using a year column plus a “day_of_year” column, where day of year runs from 1 to 365 inclusive.

ITNs

site_file$interventions$itn$implementation

Bed net implementation details

Variables

net_type Type of net
distribution_type Type of net distribution, mass-campaign or routine
distribution_day_of_year Day of the year for the distribution
distribution_lower Lower bound for possible itn_input_dist
distribution_upper Upper bound for possible itn_input_dist

Description

Supported net types currently include: “pyrethroid_only”, “pyrethroid_pbo”, “pyrethroid_pyrrole”. Net type introductions are informed by data from the Alliance for Malaria Prevention. Current available net types are: pyrethroid_only, pyrethroid_pbo and pyrethroid_pyrrole. Absent systematic, country data on mass campaign dates and locations we assume that mass campaigns occur on the first day of the year and routine distributions occur quarterly. Lower and upper bounds help to ensure that sensible model input distributions are estimated, see stop_missing_itn_input_dist() for full details. Due to differences in the availability of data sources the approach for countries within sub-Saharan Africa differs to countries outside of sub-Saharan Africa:

Within sub-Saharan Africa: The population at risk weighted mean ITN use estimates for each site are taken from the malaria atlas project.

Outside of sub-Saharan Africa: ITN use is much more heterogeneous outside of SSA and data are less systematically collected. As a result, there are strong assumptions associated with the historical scale and magnitude of ITN distributions. We make the assumption that any reported ITN distributions (as detailed by the world malaria report) are targeted such that areas with the highest baseline prevalence are prioritised first. Net use is implemented up to a maximum usage of 55% in each area, sequentially working through the targeting until the reported total number of bed nets have been allocated.

Available data on ITN use will not extend to the present year. Missing ITN use estimates to present are filled assuming a constant, continuing level of coverage. To respect the multi-year cyclical nature of ITN distribution cycles any missing estimates are filled in assuming that coverage is constant with respect to 3 years prior. For example if years 2024, 2025 and 2026 are missing then 2024 == 2021, 2025 == 2022 and 2026 == 2023.

⚠️ Warning: For ITNs to work when passed to site::site_parameters() you will need to specify a column: site_file$interventions$itn$implementation$itn_input_dist indicating the size of the model ITN distributions each year. This is not the same as ITN usage. Use site::site_usage_to_model_distribution() to convert usage to model input distributions, or call stop_missing_itn_input_dist() for full details.

Given an ITN type and level of pyrethroid insecticide resistance, the site package will link to corresponding estimates of the key ITN efficacy parameters.

Sources

🌍 | MAP ⚕️ | WHO 🦟 | Vectors


site_file$interventions$itn$use

Bed net usage estimates

Variables

itn_use ITN use
usage_day_of_year Assumed day of the year at which usage was measured

Description

Population at risk weighted average ITN use for each region. Usage measurements are assumed to occur on the first day of the year (aligns with the MAP net online model).

Sources

🌍 | MAP


site_file$interventions$itn$retention_half_life

ITN retention half-life

Variable

retention_half_life Median retention half-life (days)

Description

Retention half-life of nets in the population.

Sources

🦟 | Vectors

IRS

site_file$interventions$irs$implementation

IRS implementation details

Variables

irs_cov IRS coverage
peak_season Rainfall seasonal peak day of the year
insecticide IRS insecticide
round Spray round
spray_day_of_year Day of year of spray round

Description

As with ITNs, due to differences in the availability of data sources the approach for countries within sub-Saharan Africa differs to countries outside of sub-Saharan Africa:

Within sub-Saharan Africa: The population at risk weighted mean IRS coverage estimates for each spatial unit are summarised from the malaria atlas project

Outside of sub-Saharan Africa: IRS coverage is much more heterogeneous outside of SSA and data are less systematically collected. As a result, there are strong assumptions associated with the historical scale and magnitude of IRS campaigns. We make the assumption that any reported persons protected by IRS (as detailed by the world malaria report) are targeted such that areas with the highest baseline prevalence are prioritised first. IRS coverage
implemented up to a maximum usage of 80% in each area, sequentially working through the targeting until the reported total number of persons protected have been allocated.

It is assumed that a DDT-type insecticide is used prior to 2017, after which there is a switch to an actellic-like insecticide. Current available IRS insecticide options are: “ddt”, “actellic”, “bendiocarb” and “sumishield”. We assume a single IRS spray round per year.

Given an IRS type and level of pyrethroid insecticide resistance, the site package will link to corresponding estimates of the key ITN efficacy parameters.

Available data on IRS coverage (via MAP or the world malaria report) will not extend to the present year. Missing IRS coverage estimates to present are filled assuming a constant, continuing level of coverage.

Treatment

site_file$interventions$treatment$implementation

Treatment implementation details

Variables

year Year at which coverage changes
day_of_year Day of the year at which coverage changes
tx_cov Effective treatment coverage
prop_act Proportion of first line treatments that are an ACT

Description

The population at risk weighted mean effective treatment coverage estimates for each spatial unit are summarised from the malaria atlas project. Note, as this metric describes “effective” treatment, we implement specifically parameterised drugs in the site file with efficacy = 1. For the proportion of treatments that are an ACT, for SSA estimates by year are expanded by linear interpolation between data points and an assumption of constant coverage after the most recent data point. We assume that ACT coverage is zero before 2006, when the WHO recommendation was first issued. For outside of SSA the DHS indicator is confounded by treatment for Plasmodium vivax, and we therefore assume the mean values by year from data within SSA.

Sources

🌍 | MAP 📋 | DHS


site_file$interventions$treatment$prop_public

Proportion of treatments in the public sector

Variables

prop_public Proportion of treatments in the public sector

Description

This is useful for costing. We assume a constant proportion over time by country, estimated as the mean from all country survey estimates since 2010. For countries without survey data, we assume the median across all estimates.

Sources

📋 | DHS

Seasonal malaria chemoprevention (SMC)

site_file$interventions$smc$implementation

SMC implementation details

Variables

smc_cov SMC coverage
peak_season Rainfall seasonal peak day of the year
smc_min_age Lower bound of SMC-eligibility age range (days)
smc_max_age Upper bound of SMC-eligibility age range (days)
round Delivery round
round_day_of_year Day of year each round is delivered

Description

Historical SMC implementation and coverage estimates are fragmented. We identify historical SMC implementation areas from maps presented by both Access SMC and more recently SMC alliance. We assume a linear increase in coverage post implementation initiation up to a maximum of 80% to capture an increasing number of smaller sub-national units being targeted over time. We assume 4 rounds, centred on the seasonal peak in rainfall.

Sources

💊 | SMC


site_file$interventions$smc$drug

SMC drug

Variables

drug smc drug

Description

We assume that SP-AQ is used for SMC. This is currently the only available drug option.

Sources

⚕️ | WHO

Vaccine

site_file$interventions$vaccine$implementation

Vaccine implementation details

Variables

year Year at which coverage changes
day_of_year Day of the year at which coverage changes
r21_primary_cov Coverage of R21 primary series
rtss_primary_cov Coverage of RTS,S primary series
peak_season Rainfall seasonal peak day of the year
r21_booster1_cov Coverage of the R21 first booster
rtss_booster1_cov Coverage of the RTS,S first booster

Description

We include historical RTS,S coverage that has occurred as part of the MVIP implementation trial, sub-nationally in Malawi, Ghana and Kenya. The spatial distribution is informed from an MVIP briefing presentation.

EPI-based vaccine scale up of R21 and RTS,S has been manually collated from the UNICEF immunization dashboard. Absent sub-national data, the total doses delivered is converted into a country-wide coverage.

Sources

⚕️ | WHO 🧑‍🧒‍🧒 | UNICEF


site_file$interventions$vaccine$delivery

Vaccine delivery mode

Variables

delivery Delivery mode

Description

Can be age-based or hybrid (seasonal boosters)

Sources

⚕️ | WHO


site_file$interventions$vaccine$primary_schedule

Vaccine primary schedule ages

Variables

primary_schedule Ages of 3 primary schedule doses (days)

Description

Vaccines are assumed to have a primary schedule of 3-doses. Efficacy is assumed to start on receipt of the 3rd dose.

Sources

🧑‍🧒‍🧒 | UNICEF


site_file$interventions$vaccine$booster_spacing

Vaccine booster ages

Variables

booster_spacing Vector of booster spacing

Description

For age-based delivery booster timing is calculated relative to when an individual completes their primary vaccine series (after the third dose). If delivery is hybrid, the first booster spacing timestep is relative to the start of the year, otherwise they are relative to the last primary dose.

Perennial malaria chemoprevention (PMC)

site_file$interventions$pmc$implementation

PMC implementation information

Variables

year Year at which coverage changes
day_of_year Day of the year at which coverage changes
pmc_cov PMC coverage

Description

This intervention has been known in the past as intermittent preventative treatment of infants (IPTi). Due to the very limited (non-trial setting) implementation of PMC historically, we mostly assume 0 coverage.


site_file$interventions$pmc$drug

PMC drug

Variables

drug PMC drug

Description

We assume PMC would be implemented with SP. This is currently the only available drug option.

Sources

⚕️ | WHO


site_file$interventions$pmc$age

Variables

age Ages of 3 doses of PMC (days)

Description

Assumed an age-based delivery through EPI

Sources

⚕️ | WHO


Larval source management

site_file$interventions$lsm$implementation

Larval source management

Variables

year Year at which coverage changes
day_of_year Day of the year at which coverage changes
lsm_cov Proportion of breeding sites removed

Description

Assumed 0 coverage.